Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by toniZ1on Oct 18, 2023 5:52am
90 Views
Post# 35688443

RE:SHISEIDO WILL COMMERCIALIZE RCH-01

RE:SHISEIDO WILL COMMERCIALIZE RCH-01It wont Fall Deeper it only Can Go Up. The upside Potential is very huge. If you invest a Small amount (5000$) you could earn 50.000$ in the Next Weeks!!!

hopeium dies last :-)

If they are able to land any sort of deal the valuation will be much higher than ten times the current one. But be realistic, this won't happen in some weeks and so far they failed each time. Furthermore if they have to inject more money at this low price level your holding will be dilluted in a huge way... 

First time I invested in Replicel is over 10 years ago - if my memory is right, I bought 100k shares and after re-split I owned only 20K - propbably lost nearly all of the invested money. In 2021 again I bought 100K and so far again down about 80%, haha for sure I need to buy more because it only can go up lol.

The chance is still there but it is very small and risk losing it all is much greater. 

Haha and again dermal injector hopes - impressive, after years of not being able to produce the needle machine you guys still think this is a company maker. If they are able to bring this to the market (they were not able to bring anything into the market for decades) how many do you think they are able to sell in the short term? This is not something the world is waiting for, they would have to sell hundred of thousands if not even millions of those devices to make a revenue of relevance - I don't see that.

I am still here for the hairloss therapy and will ride it out, but I am prepared to lose all. I probably add some shares to my holding, but I won't adivse anyone to invest here because it only can go up - wake up this is a pure gamble and the possibility that they won't make it is much higher than the other way around. 
<< Previous
Bullboard Posts
Next >>